Search Results
Search results for "Glaxo Inc"
Results found for "Glaxo Inc"
- Molecular creativity in drug discovery
. • Inclusive Growth : More access for developing nations, new instructors welcome, and global partnerships FAQ 🔹 What’s included?
- Chemical Drug Matter : Rethinking the Molecules We Choose to Develop In Drug Discovery
drug matter beyond the familiar and encourages deliberate exploration of chemical novelty, rather than incremental They offer high specificity , favorable safety , and unique mechanisms , including GPCR modulation through
- A Note from Yamina: Building the Next Chapter of Dr. GPCR
partners, and GPCR experts to help teams move faster — from idea to discovery — while reducing risk and increasing The Foundry will also include Yamina’s Consulting Corner — a place for teams to get tailored scientific For the first time, University courses will be included in Premium Membership , giving members full access GPCR is evolving — thoughtfully, inclusively, and sustainably.
- GPCR Collaboration: From Models to Medicine
Over time, that transparency has built enduring partnerships , including one of Carlsson’s earliest with explain why collaborators return, why projects move forward, and why his model of collaboration is increasingly
- Predicting GPCR Function: Inside the Carlsson Lab’s Modeling Toolbox
Common questions in the group include: Can we forecast ligand efficacy or selectivity?
- Accelerating GPCR Drug Discovery: What 40 Years of Pharmacology Reveal
Allosteric modulators and biased ligands aren’t exotic outliers—they’re increasingly common outcomes
- Enhancing GPCR Research Outreach | Dr GPCR University early-bird registration ends soon!
This week's highlight includes congrats to: Miles Thompson , Alexander Hauser , Caroline Gorvin , Â et
- From Failed Experiments to Predictive GPCR Models
Today, his group includes around ten computational chemists and one in-house medicinal chemist. Unlike protein sequences, small molecule data are often fragmented, inconsistent, or unavailable, making For early-career researchers, the takeaway is direct: GPCR drug discovery will increasingly depend on
- Irreversible Drugs, Real Control: Design for Durable Target Engagement
FAQ 🔹 What’s included? Â
- Innovative Data-Driven Solutions: The pHSense Revolution
These include overexpression, tags, and fluorescent imaging.
- Transformative GPCR Insights: Unleash New Horizons in Science | Sep 9 - 15, 2024
Join leading scientists to investigate the most recent advancements in GPCR-targeted drug development, incorporating
- Understanding Enzyme Inhibition In GPCR Discovery Programs
Quick FAQ 🔹 What’s included?
- Enzyme Inhibition Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery
Your Membership Includes: Frameworks proven in real discovery programs On-demand lessons  designed for
- Assay Volume Control: Your GPCR Drug Discovery Power Lever
Fast FAQ 🔹 What’s included?
- The Truth About GPCR Product Launches: Years in the Making
Why This Matters: The GPCR toolkit scientists use today—cAMP, IP-One, and now pHSense—didn’t evolve incrementally
- Assay Sensitivity: The Hidden Lever Driving GPCR Drug Discovery
By increasing sensitivity, so-called “silent” antagonists reveal themselves as weak agonists.
- Orthosteric vs Allosteric Interactions— and the pHSense Shift in Internalization
discovery teams can accelerate identification, characterization, and lead optimization—reducing noise while increasing GPCR Premium Membership Gives You an Edge Premium provides weekly curated intelligence, including expert FAQ: Premium Membership 🔹 What’s included?
- Optimizing HTRF Assays with Fluorescent Ligands: Time-Resolved Fluorescence in GPCR Research
Terbium, a second-generation donor, is brighter than Europium (10-20 times), which increases sensitivity The ratiometric readouts correct many inconsistencies such as pipetting errors. They can be combined with second generation acceptors like d2, as well as brighter donors, further increasing
- Targeting GPCRs in the CNS: Advances in Drug Discovery Strategies
This includes diseases such as depression, Parkinson’s, schizophrenia, and Alzheimer’s.
- How to Design GPCR Drugs That Work in Vivo: Strategy, Tools, and Insights
Design smarter inotropes:  Dobutamine’s α-activity harnesses baroreflexes to increase contractility without Offered in four flexible formats  that meet scientists where they are—Anti-FLAG, Anti-IgG, and SNAP-tag included FAQ: Premium Membership 🔹 What’s included?
- Why Opposing Processes Matter for Your Next GPCR Drug
pressure in healthy volunteers might not drop blood pressure at all in heart failure patients, because increased
- Dr. GPCR Spotlights Revvity’s pHSense™ Internalization Tools
GPCR Podcast , where he shares the story behind pHSense , including its application in real-time internalization
- How Advanced GPCR Kinetics Sharpen Decision Making (and Save You Time)
Upcoming events:  Preview of Discovery on Target 2025 (Boston, Sept 24‑25), including GPCR‑Track breakout FAQ: Premium Membership 🔹 What’s included?
- Mechanism vs. Assumption: A Model-First Path to Getting GPCR MoA Right
FAQ: Premium Membership 🔹 What’s included?
- Integrating Fluorescent Ligands into Flow Cytometry: Enhancing GPCR Analysis Beyond Traditional Antibody Staining
this transition by offering optimized fluorescent ligands specifically designed for GPCR targets , including
- From Snapshots to Predictions: Why Mechanism of Action Matters
Instead of saying, “This looks like partial agonism” , you can ask: What happens if concentration increases When Binding Increases Instead of Decreases Another trap: paradoxical results. Instead, binding increases. Without a framework, this looks like an assay error.
- How a Failed Med School Dream Sparked a GPCR Biotech Revolution
how  a GPCR will respond to a given ligand — and what downstream effects it will trigger — remained incredibly The company’s goal is to model receptor dynamics — including biased signaling — to predict drug behavior He also underscores the value of developing cross-functional skills — including communication, strategy
- How to Use Statistical Methods to Strengthen Every GPCR Drug Discovery Decision
FAQ: Premium Membership 🔹 What’s included?
- Applications of Fluorescent Probes in Confocal Imaging of GPCRs: From Live to Fixed Cells
Figure 2.Left panel, confocal microscopy of living cells incubated for 1h at 37ÂşC with CELT-327. Right panel, the fluorescent signal is displaced when, after incubating with CELT-327, cells are incubated
- GPCR Happy Hour – Boston, Sept 2025
Their areas of focus include structural biology, protein production from Proteos, and nanoparticle characterization Axxam’s capabilities span the full spectrum of GPCR families, including aminergic, peptide, lipid, and Leveraging decades of experience, their services include AI-driven target identification, target validation Axxam also integrates breakthrough tools throughout the discovery process, including its pioneering organellar





























